Skip to main content

All information is provided without guarantee.

see.ip is a service from the Austrian Patent Office.

info@patentamt.at

Impressum Datenschutz

Details for 2021174262

Up to date per 02.04.2026

Actions

Details for 2021174262

Title / Product Name

SYNTHESE VON OMECAMTIV MECARBIL

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2021174262

EP Publication Number

3925950

E-Number

1608419

Language

EN

PCT Number

Publication Date

22.12.2021 A

06.09.2023 B1

Registration Date

06.09.2023

AT Publication Date

15.09.2023

Application Date

29.06.2018

Registration Number

-

Priorities

30.06.2017

US

201762527174 P

30.04.2018

US

201862664363 P

IPC

C07D 213/75 20060101AFI20211104BHEP

Maximum Duration of Protection

29.06.2038

Owner

Amgen Inc.One Amgen Center Drive Thousand Oaks, CA 91320-1799US

Representative

No representatives present

Inventor

CAILLE, Sebastien MoorparkUS

QUASDORF, Kyle Thousand OaksUS

ROOSEN, Philipp Thousand OaksUS

SHI, Xianqing Newbury ParkUS

COSBIE, Andrew VenturaUS

WANG, Fang Simi ValleyUS

WU, Zufan WalnutUS

NEERGUNDA, Archana Simi ValleyUS

QUAN, Peter Bin WoodlandUS

GUAN, Lianxiu CamarilloUS